The management of missed miscarriage in an outpatient setting: 800 versus 600 μg of vaginal misoprostol

Background: Many misoprostol regimens have been used to treat early pregnancy loss as an alternative to surgical evacuation, with differing adverse event and success rates. Aims: This study sought to compare the effectiveness and adverse effects of 800 and 600 μg of misoprostol administered vagina...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Australian & New Zealand journal of obstetrics & gynaecology 2012-02, Vol.52 (1), p.39-43
Hauptverfasser:	BARCELÓ, Francisco, DE PACO, Catalina, LÓPEZ-ESPÍN, Jose J., SILVA, Yolanda, ABAD, Lorenzo, PARRILLA, Juan J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Abortifacient Agents, Nonsteroidal - administration & dosage Abortifacient Agents, Nonsteroidal - adverse effects Abortion, Missed - drug therapy Administration, Intravaginal Adult early pregnancy failure early pregnancy loss Female Follow-Up Studies Humans miscarriage misoprostol Misoprostol - administration & dosage Misoprostol - adverse effects outpatient setting Outpatients Pregnancy Pregnancy Trimester, First Retrospective Studies Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Background: Many misoprostol regimens have been used to treat early pregnancy loss as an alternative to surgical evacuation, with differing adverse event and success rates. Aims: This study sought to compare the effectiveness and adverse effects of 800 and 600 μg of misoprostol administered vaginally for the treatment of early pregnancy failure in an outpatient setting. Methods: A retrospective, observational study of 946 women with a missed miscarriage
ISSN:	0004-8666 1479-828X
DOI:	10.1111/j.1479-828X.2011.01382.x